publication date: Sep. 13, 2019

In Brief

DeAngelis named MSK physician-in-chief, chief medical officer

Lisa M. DeAngelis was named physician-in-chief and chief medical officer at Memorial Sloan Kettering Cancer Center. 

An expert in brain cancer, DeAngelis previously served as chair of the Department of Neurology and was co-founder of MSK’s Brain Tumor Center during her 30-plus-year tenure at the institution.

DeAngelis joined MSK as a neuro-oncology fellow in 1985, working with Jerome Posner, who was MSK’s founding chair of neurology. In 1997, she was appointed chair of the Department of Neurology, a position she held until assuming the acting physician-in-chief role in September 2018. 

Her research has focused on primary brain tumors and the neurological complications of cancer and its treatment, such as cognitive impairment and strokes. She helped develop the current regimen to treat primary central nervous system lymphoma.

DeAngelis is a member of the National Academy of Medicine and a fellow of the American Academy of Neurology and the American Neurological Association. She also served previously on the board of directors for the Society for Neuro-Oncology.

As physician-in-chief, DeAngelis will direct the entire clinical care enterprise and continuum of care at MSK, leading a staff of cancer experts that includes more than 1,200 hospital attendings and almost 4,000 registered nurses.

She will be responsible for the management of all patient care services across the MSK system, including a 500-bed inpatient hospital, 13 outpatient facilities in New York City, and seven regional care sites throughout New York and New Jersey. She will also focus on clinical strategic planning and will oversee MSK’s robust clinical and translational research programs.

 

Bondy named chair of … Continue reading DeAngelis named MSK physician-in-chief, chief medical officer

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.